Integra Lifesciences Holdings Corp (IART)
23.00
+0.07
(+0.31%)
USD |
NASDAQ |
Nov 21, 16:00
23.02
+0.02
(+0.09%)
After-Hours: 05:28
Integra Lifesciences Holdings Debt to Equity Ratio: 1.187 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.187 |
| June 30, 2024 | 1.190 |
| March 31, 2024 | 1.162 |
| December 31, 2023 | 0.9444 |
| September 30, 2023 | 0.953 |
| June 30, 2023 | 0.849 |
| March 31, 2023 | 0.8596 |
| December 31, 2022 | 0.7999 |
| September 30, 2022 | 0.895 |
| June 30, 2022 | 0.9324 |
| March 31, 2022 | 0.9577 |
| December 31, 2021 | 0.9177 |
| September 30, 2021 | 0.9463 |
| June 30, 2021 | 0.9801 |
| March 31, 2021 | 1.073 |
| December 31, 2020 | 1.026 |
| September 30, 2020 | 1.094 |
| June 30, 2020 | 1.151 |
| March 31, 2020 | 1.175 |
| December 31, 2019 | 0.9515 |
| September 30, 2019 | 1.032 |
| June 30, 2019 | 0.9514 |
| March 31, 2019 | 0.9769 |
| December 31, 2018 | 0.9843 |
| September 30, 2018 | 1.049 |
| Date | Value |
|---|---|
| June 30, 2018 | 1.100 |
| March 31, 2018 | 1.835 |
| December 31, 2017 | 1.913 |
| September 30, 2017 | 1.283 |
| June 30, 2017 | 0.9837 |
| March 31, 2017 | 1.003 |
| December 31, 2016 | 0.792 |
| September 30, 2016 | 0.8352 |
| June 30, 2016 | 0.8877 |
| March 31, 2016 | 0.9403 |
| December 31, 2015 | 0.9508 |
| September 30, 2015 | 0.9995 |
| June 30, 2015 | 0.9191 |
| March 31, 2015 | 0.8967 |
| December 31, 2014 | 0.8945 |
| September 30, 2014 | 0.9081 |
| June 30, 2014 | 0.9155 |
| March 31, 2014 | 0.9261 |
| December 31, 2013 | 0.5886 |
| September 30, 2013 | 1.091 |
| June 30, 2013 | 1.052 |
| March 31, 2013 | 1.022 |
| December 31, 2012 | 1.003 |
| September 30, 2012 | 0.983 |
| June 30, 2012 | 1.017 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.7999
Minimum
Dec 2022
1.190
Maximum
Jun 2024
1.002
Average
0.9553
Median
Debt to Equity Ratio Benchmarks
| Boston Scientific Corp | 0.5254 |
| Haemonetics Corp | 1.394 |
| ResMed Inc | 0.1304 |
| Globus Medical Inc | 0.1074 |
| Perspective Therapeutics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 4.066B |
| Total Liabilities (Quarterly) | 2.544B |
| Shareholders Equity (Quarterly) | 1.522B |
| Current Ratio | 1.205 |
| Net Debt Paydown Yield | -5.39% |